Narjis Boukli

Institut Pasteur du Cambodge — KH

Immunology and Microbiology · Life Sciences

12h-index428citations24works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(9), HIV/AIDS Research and Interventions(6), SARS-CoV-2 and COVID-19 Research(6), HIV/AIDS drug development and treatment(6), SARS-CoV-2 detection and testing(6)

Publications24 total

Spatiotemporal evolution and transmission dynamics of Alpha and Delta SARS-CoV-2 variants contributing to sequential outbreaks in Cambodia during 2021
Communications Medicine·2024· 1 citedOpen Access
One assay to test them all: Multiplex assays for expansion of respiratory virus surveillance
Frontiers in Medicine·2023· 16 citedOpen Access
ONE ASSAY TO TEST THEM ALL: COMPARING MULTIPLEX ASSAYS FOR EXPANSION OF RESPIRATORY VIRUS SURVEILLANCE
2023· 4 citedOpen Access
Genomic epidemiology of SARS-CoV-2 in Cambodia, January 2020 to February 2021
Virus Evolution·2022· 6 citedOpen Access
Young people seeking sexual health care but not returning for results
Sexually Transmitted Infections·2021
Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients
European Journal of Clinical Microbiology & Infectious Diseases·2021· 19 citedOpen Access
Caution in interpretation of SARS-CoV-2 quantification based on RT-PCR cycle threshold value
Diagnostic Microbiology and Infectious Disease·2021· 22 citedOpen Access
High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies
Journal of Clinical Microbiology·2020· 21 citedOpen Access
Is Madagascar at the edge of a generalised HIV epidemic? Situational analysis
Sexually Transmitted Infections·2020· 23 cited
Evaluation of 31 Commercial SARS-CoV-2 Serology Assays
SSRN Electronic Journal·2020· 1 citedOpen Access
Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?
Journal of Antimicrobial Chemotherapy·2019· 17 cited
Intérêt et limites de l’utilisation des TROD Multiplex VIH/syphilis en CeGIDD
Médecine et Maladies Infectieuses·2019· 1 cited
Utility of HIV-1 DNA genotype in determining antiretroviral resistance in patients with low or undetectable HIV RNA viral loads
Journal of Antimicrobial Chemotherapy·2018· 20 citedOpen Access
Targeted HIV Screening in Eight Emergency Departments: The DICI-VIH Cluster-Randomized Two-Period Crossover Trial
Annals of Emergency Medicine·2017· 31 citedOpen Access
Sensitivity of the STAT-VIEW rapid self-test and implications for use during acute HIV infection
Sexually Transmitted Infections·2017· 4 cited
COL 5-03 - Statut vaccinal et infection génitale par les HPV en France
Médecine et Maladies Infectieuses·2016
Performance of genotypic algorithms for predicting tropism of HIV-1CRF02_AG subtype
Journal of Clinical Virology·2016· 6 citedOpen Access
Assessment of Cetirizine, an Antihistamine, to Prevent Cutaneous Reactions to Nevirapine Therapy: Results of the Viramune‐Zyrtec Double‐Blind, Placebo‐Controlled Trial
Clinical Infectious Diseases·2004· 23 cited
Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy
AIDS·2003· 1 cited
[Predictive factors of virologic response to antiretroviral treatment with a protease inhibitor in HIV infection].
PubMed·2001· 3 cited
page 1 of 2Next →

Frequent Co-authors

Laurence Morand‐Joubert(14), Joël Gozlan(8), Dominique Costagliola(5), Christine Katlama(4), Nadia Valin(4), Corinne Amiel(4), Pierre‐Marie Girard(4), Marie‐Laure Chaix(4), Anne‐Geneviève Marcelin(4), Diane Descamps(4), Viseth Srey Horm(4), Erik A. Karlsson(4), Anne‐Marie Fillet(3), Sophie Matheron(3), Catherine Leport(3), Dominique Salmon(3), Sarah Maylin(3), Laurence Baril(3), Sidonie Lambert-Niclot(3), Djeneba Fofana(3)